TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Renapharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
30,599
|
28,528
|
22,531 |
Financial expenses |
78
|
30
|
107 |
Earnings before taxes |
6,689
|
6,975
|
7,765 |
EBITDA |
7,264
|
7,472
|
8,990 |
Total assets |
44,840
|
35,128
|
25,347 |
Current assets |
21,969
|
18,389
|
9,486 |
Current liabilities |
9,790
|
7,291
|
2,046 |
Equity capital |
26,842
|
18,819
|
12,210 |
- share capital |
101
|
95
|
98 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.9%
|
53.6%
|
48.2% |
Turnover per employee |
7,650
|
7,132
|
7,510 |
Profit as a percentage of turnover |
21.9%
|
24.4%
|
34.5% |
Return on assets (ROA) |
15.1%
|
19.9%
|
31.1% |
Current ratio |
224.4%
|
252.2%
|
463.6% |
Return on equity (ROE) |
24.9%
|
37.1%
|
63.6% |
Change turnover |
47
|
6,674
|
5,732 |
Change turnover % |
0%
|
31%
|
34% |
Chg. No. of employees |
0
|
1
|
-1 |
Chg. No. of employees % |
0%
|
33%
|
-25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.